Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parag Parekh

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Plos One|March 14, 2013
Selection of an aptamer antidote to the anticoagulant drug bivalirudinJennifer A Martin, Parag Parekh, Youngmi Kim, et al.
Investigative Ophthalmology & Visual Science|December 24, 2003
Diurnal axial length fluctuations in human eyesRichard A Stone, Graham E Quinn, Ellie L Francis, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Plos One|March 14, 2013
Selection of an aptamer antidote to the anticoagulant drug bivalirudinJennifer A Martin, Parag Parekh, Youngmi Kim, et al.
Investigative Ophthalmology & Visual Science|December 24, 2003
Diurnal axial length fluctuations in human eyesRichard A Stone, Graham E Quinn, Ellie L Francis, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Pageof 3